LBA Wealth Management’s Pfizer PFE Stock Holding History

LBA Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$903K	Sell	27,813 -222	-0.8%	-$7K	0.48%	37
2016 Q4	$864K	Buy	28,035 +978	+4%	+$29.9K	0.47%	37
2016 Q3	$869K	Buy	27,057 +893	+3%	+$29.9K	0.49%	35
2016 Q2	$874K	Sell	26,164 -1,106	-4%	-$35.3K	0.49%	40
2016 Q1	$767K	Sell	27,270 -1,150	-4%	-$32.8K	0.44%	40
2015 Q4	$870K	Sell	28,420 -36	-0.1%	-$1.13K	0.5%	32
2015 Q3	$848K	Buy	28,456 +388	+1%	+$12.4K	0.53%	32
2015 Q2	$893K	Sell	28,068 -155	-0.5%	-$5.05K	0.56%	34
2015 Q1	$932K	Sell	28,223 -54	-0.2%	-$1.72K	0.59%	35
2014 Q4	$836K	Sell	28,277 -2,948	-9%	-$84.5K	0.55%	37
2014 Q3	$876K	Buy	31,225 +795	+3%	+$22.3K	0.61%	37
2014 Q2	$857K	Sell	30,430 -101	-0.3%	-$2.88K	0.7%	36
2014 Q1	$930K	Sell	30,531 -897	-3%	-$26.7K	0.76%	34
2013 Q4	$913K	Buy	+31,428	New	+$915K	0.75%	33

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

LBA Wealth Management's PFE Position: Q1 2017 in Review

LBA Wealth Management reduced its Pfizer (PFE) stake by 0.79% in Q1 2017, selling an estimated $7K and leaving 27,813 shares worth $903K. The position accounts for 0.48% of the portfolio, ranked #37.

LBA Wealth Management first reported a position in PFE in Q4 2013 and has held it in 14 quarters since. The position peaked at $932K in Q1 2015. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

LBA Wealth Management held 27,813 shares of Pfizer worth $903K as of Q1 2017.
LBA Wealth Management sold 222 Pfizer shares in Q1 2017, an estimated $7K.
Pfizer made up 0.48% of LBA Wealth Management's portfolio in Q1 2017, its #37 holding.
LBA Wealth Management first reported a position in Pfizer in Q4 2013 and has held it in 14 quarters since.
LBA Wealth Management's Pfizer position peaked at $932K in Q1 2015.
2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on LBA Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.